Skip to content

Cardiomyopathy Familial Restrictive 2 C1865071

Published: July 22, 2026Updated: August 27, 2026

A genetic form of heart muscle disease characterized by stiff heart chambers that cannot fill normally. Management focuses on symptom relief and preventing complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dyspnea

(cardiovascular)

Fatigue

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Diuretic therapy

Loop diuretics as first-line therapy to manage systemic venous congestion and peripheral edema. Careful dosing is essential to balance symptom relief against the risk of prerenal azotemia.

medication
3

Rate control for atrial arrhythmias

Management of atrial fibrillation or flutter with rate-controlling agents, as these arrhythmias are common in restrictive physiology. Beta-blockers or digoxin may be used depending on ventricular function.

medication

Additional treatment options

Palliative care consultation

Early integration of palliative care for symptom management and quality of life optimization. Includes advanced care planning and symptom-focused interventions for dyspnea and pain.

complementary

Anti-inflammatory and low-sodium diet

Dietary modifications including sodium restriction and potentially anti-inflammatory foods when the underlying cause involves inflammatory conditions. Professional nutritional counseling is recommended.

dietary

Serial NT-proBNP and cardiac imaging

Tracking of natriuretic peptide levels alongside echocardiographic parameters to assess disease progression and therapeutic response. Useful for timing of intervention escalation.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cardiomyopathy Familial Restrictive 2 C1865071?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270-276.

guideline2008
2

Rashedi N, Nagueh S. Restrictive cardiomyopathy: current diagnostic and management strategies. Cardiol Clin. 2020;38(4):549-562.

review2020
3

Mogensen J, van Tintelen P, Fokstuen S, et al. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions. Int J Cardiol. 2015;181:17-24.

clinical_trial2015
4

Hutchinson J, Fei W, Sun Q, et al. Mortality and morbidity in familial restrictive cardiomyopathy: a systematic review and meta-analysis. Heart Fail Rev. 2022;27(5):1623-1634.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Cardiomyopathy Familial Restrictive 2 C1865071. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy